{"filing":{"accession_number":"0001213900-26-095686","cik":"0001560293","ticker":"TNONW","company_name":"Tenon Medical, Inc.","form":"8-K","filing_date":"2026-08-31","report_date":"2026-08-27","primary_document":"ea0303883-8k_tenon.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1560293/000121390026095686/ea0303883-8k_tenon.htm"},"events":[{"id":30577,"run_id":28026,"accession_number":"0001213900-26-095686","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"summary":"Tenon Medical completed a $3.0 million private placement on August 31, 2026, issuing 597,610 shares of common stock (or pre-funded warrants) and warrants to purchase 1,058,517 additional shares under Section 4(a)(2) and Regulation D exemptions. The company intends to use proceeds for debt repayment and working capital.","company_name":"Tenon Medical, Inc.","ticker":"TNONW","filing_date":"2026-08-31","form":"8-K","submitted_at":null,"items":[{"id":33207,"accession_number":"0001213900-26-095686","item_number":"1.01","item_title":"Entry into a Material Definitive","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Tenon Medical entered into a securities purchase agreement on August 27, 2026, and closed a private placement on August 31, 2026, issuing pre-funded warrants to purchase 597,610 shares and Series A warrants to purchase 1,058,517 shares for gross proceeds of approximately $3.0 million. This is a classic unregistered private placement of equity securities with warrant coverage, characteristic of dilutive issuances at small- and mid-cap medical device companies raising capital. The company intends to use proceeds for debt repayment and working capital, signaling potential financial stress.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T19:41:44.040797+00:00","company_name":"","ticker":null,"filing_date":""},{"id":33208,"accession_number":"0001213900-26-095686","item_number":"3.02","item_title":"Unregistered","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Tenon Medical completed a $3.0 million private placement of unregistered securities, issuing 597,610 shares of common stock (or pre-funded warrants) plus warrants to purchase 1,058,517 additional shares under Section 4(a)(2) and Regulation D exemptions. This is a classic dilutive equity issuance to raise capital, material to investors assessing ownership dilution and the company's capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T19:41:44.040797+00:00","company_name":"","ticker":null,"filing_date":""},{"id":33209,"accession_number":"0001213900-26-095686","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Tenon Medical announced the pricing (August 28) and closing (August 31) of a $3.0 million private placement of 597,610 shares of common stock (or pre-funded warrants) plus warrants to purchase 1,058,517 additional shares. This is an unregistered equity issuance under Section 4(a)(2) and Regulation D, representing a dilutive capital raise typical of small-cap medical device companies. The filing explicitly discloses the securities purchase agreement, pricing, and closing of the offering.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T19:41:44.040797+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":33207,"accession_number":"0001213900-26-095686","item_number":"1.01","item_title":"Entry into a Material Definitive","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Tenon Medical entered into a securities purchase agreement on August 27, 2026, and closed a private placement on August 31, 2026, issuing pre-funded warrants to purchase 597,610 shares and Series A warrants to purchase 1,058,517 shares for gross proceeds of approximately $3.0 million. This is a classic unregistered private placement of equity securities with warrant coverage, characteristic of dilutive issuances at small- and mid-cap medical device companies raising capital. The company intends to use proceeds for debt repayment and working capital, signaling potential financial stress.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T19:41:44.040797+00:00","company_name":"Tenon Medical, Inc.","ticker":"TNONW","filing_date":"2026-08-31"},{"id":33208,"accession_number":"0001213900-26-095686","item_number":"3.02","item_title":"Unregistered","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Tenon Medical completed a $3.0 million private placement of unregistered securities, issuing 597,610 shares of common stock (or pre-funded warrants) plus warrants to purchase 1,058,517 additional shares under Section 4(a)(2) and Regulation D exemptions. This is a classic dilutive equity issuance to raise capital, material to investors assessing ownership dilution and the company's capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T19:41:44.040797+00:00","company_name":"Tenon Medical, Inc.","ticker":"TNONW","filing_date":"2026-08-31"},{"id":33209,"accession_number":"0001213900-26-095686","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Tenon Medical announced the pricing (August 28) and closing (August 31) of a $3.0 million private placement of 597,610 shares of common stock (or pre-funded warrants) plus warrants to purchase 1,058,517 additional shares. This is an unregistered equity issuance under Section 4(a)(2) and Regulation D, representing a dilutive capital raise typical of small-cap medical device companies. The filing explicitly discloses the securities purchase agreement, pricing, and closing of the offering.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-31T19:41:44.040797+00:00","company_name":"Tenon Medical, Inc.","ticker":"TNONW","filing_date":"2026-08-31"}]}